Methods for Imaging Inflammation and Transendothelial Migration in vivo and ex vivo (2024)

  • Journal List
  • HHS Author Manuscripts
  • PMC10309184

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice

Methods for Imaging Inflammation and Transendothelial Migration in vivo and ex vivo (1)

About Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;

Curr Protoc. Author manuscript; available in PMC 2024 Apr 1.

Published in final edited form as:

Curr Protoc. 2023 Apr; 3(4): e739.

doi:10.1002/cpz1.739

PMCID: PMC10309184

NIHMSID: NIHMS1886781

PMID: 37078364

Vivienne Fang,*# Maureen E. Haynes,*# Vanessa Hayashi,* Erika Arias,* Jeremy A. Lavine,** David P. Sullivan,* and William A. Muller*

Author information Copyright and License information PMC Disclaimer

The publisher's final edited version of this article is available at Curr Protoc

Associated Data

Data Availability Statement

Abstract

Inflammation is the body’s response to injury and harmful stimuli and contributes to a range of infectious and non-infectious diseases. Inflammation occurs through a series of well-defined leukocyte-endothelial interactions, including rolling, activation, adhesion, transmigration, and subsequent migration through the extracellular matrix. Being able to visualize the stages of inflammation is important for a better understanding of its role in diseases processes. Detailed in this article are protocols for imaging immune cell infiltration and transendothelial migration in vascular tissue beds, including those in the mouse ear, cremaster muscle, brain, lung, and retina. Also described are protocols for inducing inflammation and quantifying leukocytes with FIJI imaging software.

Keywords: Inflammation, transendothelial, diapedesis, intravital microscopy

INTRODUCTION:

Inflammation is critical to responding to and resolving insults, as infiltration of immune cells known as leukocytes contributes to the expulsion and/or destruction of damaging mediators. However, while it is critical to the body’s response to infection and injury, inflammation is a double-edged sword, also underlying the pathology of most diseases. As a result, it is of the utmost importance to understand and characterize inflammatory responses. Throughout history, the inflammatory response has been characterized through a number of methods, with imaging being of great importance due to the ability to see inflammatory processes occurring in various tissues under physiologically normal conditions and in disease. Diseases manifest their pathology in different organs, so it is useful to study inflammation in the appropriate vascular beds. To study the response of leukocytes to various insults in different vascular beds and to characterize the transendothelial migration step of the inflammatory cascade, we have established and calibrated several methods of inducing and imaging inflammation. Here we describe methods by which to image leukocyte-endothelial cell interactions in the murine skin, cremaster muscle, brain, lung, and eye along with techniques for image analysis and post-processing.

BASIC PROTOCOL 1

Croton Oil Dermatitis

This protocol is used to study acute inflammation in the skin of mice. The tissue is later stained with appropriate antibodies and imaged to determine the percentage of transendothelial migration (TEM) events. We developed this protocol to study TEM in vivo.

This protocol is best suited for experiments in which the purpose is to test drugs or treatments that are expected to block inflammation. Mice that have been exposed to said drugs or treatments have their ears challenged with a dose of the inflammatory substance, croton oil. Under control conditions where mice have not received any treatment, the ears become acutely inflamed; however, if the tested drug has anti-inflammatory properties, it is expected that the ears will have decreased inflammation despite application of croton oil.

Croton oil is a stimulant of inflammation and at high concentrations can cause severe irritation when exposed to skin. The active ingredient is phorbol myristate acetate (PMA), an activator of protein kinase C and a known tumor promoter. It is important to wear gloves when handling the oil. We recommend that you use double-gloves and keep the bottle of croton oil in the secondary containment of a 50 mL conical tube to prevent potential spillage.

Materials:

Starting materials:

Mice (we have tested FVB, C57BL/6, 129S backgrounds)

Carrier solution (see recipes in Reagents and Solutions)

Croton oil mixture (see recipes in Reagents and Solutions)

Nair hair-removal lotion

DPBS, 1X without calcium & magnesium (CORNING, lot 26321007)

Fixing solution (see recipe in Reagents and Solutions)

Bovine serum albumin (BSA) solution (see recipe in Reagents and Solutions)

Permeabilization buffer (see recipe in Reagents and Solutions)

Normal goat serum (NGS) (Jackson, cat. no. 005-000-121)

Normal mouse serum (NMS) (Jackson, cat. no. 015-000-120)

Anti-PECAM 2H8 (Millipore Sigma, cat. no. MAB1398Z)

Anti-S100A9 (Abcam, cat. no. ab105472)

Fluorophore-conjugated goat anti-Armenian hamster secondary

Fluorophore-conjugated goat anti-rat secondary

FluorSave mounting reagent (Calbiochem, cat. no. 345789–20L)

Hardware and instruments:

1.5 mL microfuge tubes

Isoflurane anesthetic apparatus

Heating pad

CO2 tank with mouse euthanasia apparatus

Cotton swabs

Dissection scissors and tweezers

15 mL conical tubes

12 well flat bottom plate

Plate shaker

100 mm culture dish

Dissection microscope

24 well flat bottom plate

Aluminum foil

Glass microscope slides

Coverslips #1.5, 22mmx22mm

Spinning disk confocal microscope

Protocol steps with step annotations:

This protocol starts with croton oil application. Any experimental conditions to be tested must be performed on the mice prior to the steps listed in this protocol. There is no definite number of mice that should be processed per batch, but 6 mice or less would be reasonable for the workload.

Day 1

  1. Prepare the carrier and croton oil mixtures in two 1.5mL microfuge tubes.

  2. Set the air flow rate to 2 L/min and anesthetize the mice with isoflurane. Wait for the mouse’s breathing to slow down enough to indicate a sufficient plane of anesthesia.

    This procedure does not have to be performed under anesthesia if the investigator is comfortable “scruffing” the mouse or if there is a gentle way of immobilizing the mouse’s head. For consistency, the croton oil and carrier mixtures must be applied evenly and completely, which is easier when the mouse’s head is immobilized.

  3. Pipette 10 μL of carrier mixture onto the back of the left ear and 10 μL of the same carrier mixture onto the front side.

  4. Pipette 10μL of croton oil onto the front and back of the right ear. Repeat for all mice.

  5. Leave mice in cage with access to a heating pad for 5 hours.

  6. Sacrifice mice with CO2 asphyxiation and cervical dislocation.

  7. Rub Nair on both sides of the ears using a cotton swab, leave for a minute and wipe off with disposable wipes to remove hair. Cut the ears off the mouse. Pour 12 mL of 1X DPBS into each of two 15 mL conical tubes, and place an ear into each tube, keeping track of which ear received which treatment. Shake the tubes to wash the Nair off the ears.

    The bubbles will automatically bring the ears to the surface of DPBS, so they can be easily removed with tweezers. The DPBS can be reused for more mice, but it is recommended to pour fresh DPBS when it is murky.

  8. Place the ears into a labeled 12 well flat bottom plate. Fill each of the wells with 1mL fresh fixing solution. Leave the plates on a shaker for 0.5–1hr at room temperature.

  9. Add 1X DPBS to a 100 mm culture dish. Temporarily transfer 1 ear at a time to this 100 mm dish and place under dissection microscope to zoom in on the cut edge of the ear. Separate the front and back sides of the ear by gripping each side at the cut edge with fine forceps, and then slowly pulling them apart. Keep track of which side is the epithelial side and which is the side with interstitial tissue / endothelium.

  10. Making sure the interstitial tissue/endothelium side of the ear is facing down, place each ear half individually in a 12 well plate with fresh fixing solution. Leave the plate on a shaker overnight at 4°C.

    The epithelial (outer side is hydrophobic/waxy) so the ear halves may float with the interstitial above the fixative if not placed interstitial side down.

Day 2

  1. Wash ears with 1X DPBS 10 min × 3 times at room temperature.

  2. Place each half-ear in the same orientation as before into a 24 well plate with 500 mL permeabilization buffer in each well. Leave to permeabilize on a shaker overnight at 4°C.

Day 3

  1. Wash ears with 1X DPBS 10 min × 3 times at room temperature.

  2. Dilute anti-PECAM 2H8 and anti-S100A9 in a solution of 2.5% bovine serum albumin (BSA) + 5% normal goat serum (NGS). Add 250 mL antibody mixture into each well of a 24 well plate. Place each half-ear in the same orientation as before in the wells. Leave the plate on a shaker overnight at 4°C.

    Recommended concentrations are 9 μg/ml anti-PECAM and 2 μg/ml anti-S100A9, which corresponds to dilutions of 1:200 for anti-PECAM 2H8 and 1:500 for anti-S100A9 from the commercial sources stated above.

Day 4

  1. Wash ears with 1X DPBS 10 min × 3 times at room temperature.

  2. Dilute goat anti-Armenian hamster secondary and goat anti-rat secondary in a solution of 2.5% BSA + 5% NGS + 5% normal mouse serum. Leave this mixture for 15 min on ice to pre-absorb the secondary antibodies. Add 250 mL of the mixture into each well of a 24 well plate. Place each half-ear in the same orientation as before in the wells. Cover the plate with aluminum foil to protect the fluorophores. Leave the plate on a shaker for 4 hrs at room temperature.

  3. Wash ears with 1X DPBS 10 min × 3 times at room temperature.

  4. Mount specimens on glass microscope slides. Place two drops of FluorSave mounting reagent onto the slide, and place the half-ear onto the slide with the epithelial side facing down. Add as many drops of FluorSave as needed and place coverslip on top. Allow them to dry in a dark place for at least 1 hr at room temperature.

    Place the coverslip delicately so that as few bubbles as possible get trapped. Depending on the shape of the half-ears, they might need to be trimmed so that they can lay flat on the slide. It is recommended to use a generous amount of FluorSave reagent, because it has a tendency to shrink when dry.

  5. Store slides in a slide holder to maintain them protected from light and store at 4°C until imaging.

    Slides can be stored for several months without significantly decreasing the quality of the images, but it is still recommended to image them soon after mounting.

Imaging

  1. Turn on the spinning disk confocal microscope. Place the slide on the mechanical stage and add a drop of immersion oil on top of the coverslips. Adjust the position of the slide so that the objective lens (40X oil) is directly above the ear that received carrier mixture. Lower the objective until it barely touches the drop of oil.

    Since this protocol uses fixed samples for imaging, a laser scanning confocal can be a replacement for the spinning disk confocal.

  2. Focus the image until the blood vessels are visible in the goat anti-Armenian hamster secondary channel.

  3. Switch to the goat anti-rat secondary channel, and scan to verify that there are few to no leukocytes (0–2 per field).

    The ears that received carrier mixture should not have inflammation, otherwise they cannot serve as control conditions for the ears on which acute inflammation was triggered using croton oil mixture.

  4. Adjust the position of the slide so that the objective lens is directly above the ear that received croton oil mixture. Lower the objective and focus the image as in step 2.

  5. Scan the sample for blood vessels, whose cell-to-cell junctions have a cobblestone pattern, and that have a diameter between 15μm and 50μm, ideally between 30μm and 50μm.

    These are most likely to be post-capillary venules, where neutrophils extravasate. Avoid vessels that have highly elongated, thin endothelial cells because these are likely arteries.

  6. Switch the laser to the goat anti-rat secondary channel. Take a Z-stack if there are 10–30 leukocytes in the field.

  7. Repeat steps 5 and 6 for 10 or more fields in each ear that received croton oil mixture.

  8. Repeat entire imaging process for all the experimental conditions.

Counting leukocytes

  1. On each picture, look at the Z-plane and score how many leukocytes are inside and outside the vessels (area within 50mm from a venule). If there are leukocytes that are not fully inside nor outside, count them separately.

    Avoid counting leukocytes inside the vessels that are not in contact with the walls of the vessels, as much as possible. Avoid counting leukocytes that are outside of vessels with low amount of fluorescence, because these are likely to be resident macrophages.

  2. Calculate the percent TEM per image. Divide the number of leukocytes that were outside the vessels by the total amount of leukocytes in the given image. Repeat this for all the images.

  3. Calculate the average percent TEM. Take the average of the values from step 2. Compare the average percent TEM between/among experimental conditions and perform statistical tests as needed.

    If the average percent TEM in an experimental condition is lower than the control condition, it means that TEM was blocked to a given extent by the condition the mouse was exposed to.

ALTERNATE PROTOCOL 1:

Croton Oil Dermatitis Using Genetically Fluorescent Mice

If the mice used in the experiment have fluorescent neutrophils (eg. LysM-eGFP, Catchup), it is possible to skip the steps of the protocol that involve staining leukocytes with antibodies post-fixation.

[Additional] Materials:

Mice with fluorescent neutrophils (eg. LysM-eGFP, Catchup)

Non-blocking CD31 (PECAM) monoclonal antibody (390) conjugated with fluorophore of choice

Protocol steps with step annotations:

Day 1

Between steps 5 and 6 in the original protocol, perform the following steps, if applicable.

  1. Anesthetize the mice as in step 2.

  2. Take one mouse and inject 100 μL fluorescent 390 antibody retro-orbitally. Wait 5 minutes.

Recommended concentration is 0.25 mg/mL. As this will label endothelial cells, the steps can be omitted if the mouse has been genetically engineered with a fluorescent endothelial cell marker.

Steps in Day 2 and 3 can be ignored. Continue from Day 4 onwards in the original protocol.

Commentary

Background information for Basic and Alternate Protocols 1:

Transendothelial migration (TEM) is a step in the inflammatory cascade that involves leukocytes crossing the walls of blood vessels. It involves hom*ophilic binding of neutrophil PECAM to PECAM on the endothelial junctions, and sequential binding of CD99L2 and CD99 (Rutledge et al., 2022) . Studying TEM is a promising endeavor because it opens up more possibilities for anti-inflammatory drug development, given that many of the molecules involved are specifically expressed in endothelial junctions.

The current protocol, “Croton oil dermatitis”, is one to aid in the study of TEM. The advantage of this protocol is that it allows for in vivo experimentation that does not require complex equipment or high level of skill. The disadvantage is that it is an end-point assay, unlike protocols involving intravital fluorescence microscopy (IVM), which can record the movement of leukocytes in real time. Even then, it is a useful assay to complement the findings from IVM in a different tissue bed.

The current protocol can be used on any mouse; thus, the researcher is at liberty to study the effect of pharmacological or genetic manipulations on TEM. Croton oil is an irritant that induces acute inflammation at low concentration when applied to the skin. This inflammation will be visualized at the end of the protocol, and the effect on TEM quantified by counting how many leukocytes are inside and outside the blood vessels. If TEM is blocked, it is expected that there will be more leukocytes inside the vessels, unable to transmigrate, compared to those in wild type mice or other mice used as control.

Critical Parameters:

Though the protocol has been used in C57BL/6 and FVB mice strains with success, it will be best to do a croton oil dose-response experiment on the strain of mice that will be used in the experiment, as too little croton oil will recruit too few leukocytes and too much will severely hurt the mice. In response to severe irritation the mice will scratch their ears resulting in excoriation and local trauma, which can hinder interpretation of the results. The best croton oil concentration will be one in which, when imaged with a 40X objective lens, there are several fields of view containing 10–20 leukocytes.

If the fluorophore-conjugated antibodies used are sensitive to light, it is recommended to shield the ears from light using aluminum foil from the step of antibody incubation onwards.

Troubleshooting

Table 1 lists problems that may arise with the croton oil dermatitis procedures, along with their possible causes and solutions.

Table 1.

Troubleshooting Guide for Croton Oil Dermatitis

ProblemPossible CauseSolution
The front and back sides of the ear tear when trying to separate themFixation time was not enoughLeave in fixing solution for 10 min longer
Poor signalEars were over-fixedFix for 1–2 hrs instead of overnight
The ear was mounted with the epithelial side facing the lensTake the ear out of the slide, wash with 1X DPBS, and mount on a new slide with the epithelial side facing down
Microscope settings are not idealAdjust sensitivity and/or auto-contrast settings
Too little/too much inflammation (<10 or >30 leukocytes per 170μm × 170μm field)Croton oil concentration is too low/too highIncrease/decrease croton oil concentration to 1% or 2% v/v

Open in a separate window

Understanding results:

If there is not a block in transmigration, it is expected that most of the neutrophils will be located outside of blood vessels (Figure 1A). If there is a block in transmigration, it is expected that most of the neutrophils will be inside the vessels (Figure 1B). One will likely encounter imaging fields that have leukocytes inside and outside the vessels, depending on how responsive the mouse strain is to inflammation (Figure 1C).

Open in a separate window

Figure 1.

Sample images of neutrophils (S100A9, cyan) extravasation from blood vessels (PECAM, red) collected using a spinning disk confocal microscope. The degree of extravasation can vary from full extravasation (row A) to no extravasation, which indicates a TEM block (row B). Most images will likely contain neutrophils both inside and outside vessels (row C). Scale bars are 50 μm.

Time Considerations:

This protocol takes 4 days until samples are loaded on microscope slides. The imaging and counting processes take a variable number of hours, depending on how many mice are being imaged and what microscope settings are used.

BASIC PROTOCOL 2:

Intravital microscopy of the mouse cremaster muscle

The cremaster muscle is an extremely thin, muscular sheath that surrounds the testes in male mice. This protocol describes the methods by which we surgically expose, mount, and image the vasculature of the cremaster muscle to study infiltration of inflammatory cells in vivo in real time. Intravital microscopy (IVM) of the cremaster muscle is used to visualize the movement of inflammatory cells like leukocytes. This protocol is useful for visualizing the response to localized inflammatory stimuli. IL-1β is routinely used as generic stimulus, particularly when studying general leukocyte adhesion and diapedesis. Other inflammatory stimuli could be used to interrogate specific leukocyte subsets and/or other components of the inflammatory cascade.

Materials:

Starting materials:

Mice with genetically-encoded fluorescent leukocytes, wild-type or knockouts, with or without a treatment of interest (see Fluorescent Mice section below)

DPBS, 1X without calcium & magnesium (CORNING, lot 26321007)

Recombinant mouse interleukin-1β (IL-1β) (R&D Systems, 401-ML-005/CF)

Ketamine hydrochloride (Covetrus, NDC# 11695-0703-1)

Xylazine (Akorn Inc., NDC# 59399-110-20)

Anti-PECAM antibody conjugated to a fluorophore (EMD Millipore, CBL1337 clone 390, Rat anti-mouse, non-blocking)

Nair hair-removal lotion

Perfusion buffer (see recipe in Reagents and Solutions)

Tyrode’s Salts (Millipore Sigma, T2145–10X1L)

Sodium Bicarbonate (Millipore Sigma, T2145)

Hardware and Instruments:

Plexiglas platform with glass window

Silicone stage with quartz pedestal

Dissecting microscope (Leica or equivalent)

Fine forceps and scissors

Threaded needle

Suture needles bent into an “L” shape

Dissecting pins

Buffer warmer

Cotton tip applicators

Heating pad

Syringe pump

Confocal microscope (Nikon or equivalent) with 20× water-immersion objective

Protocol steps with step annotations:

  1. Inject 150 μl of PBS containing 50 ng of mouse IL1-β intrascrotally (i.s.; Figure 2A) The injection should be shallow, just below the dermis. A noticeable bulge from the volume injected usually indicates correct depth. After injection, palpate the scrotum with the plunger end of the syringe to gently distribute the inflammatory stimulus.

    Open in a separate window

    Figure 2.

    Images showing (A) injection of IL-1ß inflammatory stimulus into the right scrotum, (B) the scrotal region post hair-removal with Nair®, (C) tying of the urethra to prevent urination during the procedure, and (D) surgery set-up including securing the hindlegs to the plexiglass.

  2. Wait 3.5 h. Exact timing depends on several factors including the cell type/process to be examined and the skill of the surgeon. The typical target time to start imaging is on the early side of the peak leukocyte recruitment window.

  3. Anesthetize the mouse by intraperitoneal injection of ketamine and xylazine (100 mg/kg and 10 mg/kg body weight, respectively). Administer supplementary anesthetic doses (~25 μl containing 25 mg/ml ketamine and 1.25 mg/ml xylazine) upon positive response to a foot pad pinch or whisker stimulation (typically every 30–45 min).

  4. Inject 100 mg of fluorescently conjugated non-blocking anti-PECAM antibody (clone 390) and/or any additional labeling antibodies of interest intra-venously or retro-orbitally.

  5. Remove hair on the scrotum and surrounding area with the depilatory gel, Nair® (Figure 2B). Total area of exposed skin should be 1 cm by 1 cm.

  6. Secure the mouse in a supine position on a Plexiglas platform containing an internal heating pad set to ~37°C. Use suture to securely tie the urethra to prevent urination during the procedure. Tape each lower leg such that it straddles the edge of a glass window in the platform (Figure 2C, ​,DD).

  7. Position the silicone stage (see support protocol) in modeling clay on the Plexiglas platform (Figure 2D).

  8. Grab the outer skin of the scrotum and secure it with a needle to the silicone mount. Make a ~1 cm incision along the left ventral side of the scrotum (Figure 3A, ​,BB).

    Open in a separate window

    Figure 3.

    Images showing (A, B) initial incision and opening of the scrotum, (C) isolating the testicl* encompassed by the cremaster muscle, (D) and the cremaster muscle secured to the silicone stage with suture needles. Scale bars are 0.5 cm.

  9. Grasp the base of the cremaster muscle and gentle pull the tissue and testicl* it encompasses out of the body cavity (Figure 3C).

  10. Secure the tissue across the quartz pedestal and secured using bent suture needle(s) (Figure 3D).

  11. Begin perfusion with warmed perfusion buffer. Allow buffer to drain directly onto the objective by bringing the perfusion tube directly next to it. The buffer can then drain down onto the tissue in a way that does not induce motion artifacts throughout the rest of the protocol. Using a syringe pump helps provide for a smooth steady flow and is preferable to a peristaltic pump.

  12. Carefully remove connective tissue from the cremaster muscle using forceps by grabbing small pieces of the overlying sheath and pull them down and away from the body.

  13. Open the muscle using microsurgery scissors by making a single distal-to-proximal incision that avoids severing as many large vessels as possible.

    The bleeding from small vessels will clot naturally; large vessels are closed either by pinching the vessel near the opening with fine forceps or pinning the vessel to the silicone pedestal.

  14. Cut the small tissue connection and vessel running from the epididymis (and associated testicl*) to the cremaster muscle using microsurgery scissors and replace them in the inguinal canal (Figure 4A).

    Open in a separate window

    Figure 4.

    Images showing (A) separation of the cremaster muscle from the testicl* and cutting of the vessel running from the epididymis, (B) birds-eye view of the cremaster muscle with testis and epididymis retracted, (C) imaging of the cremaster, (D) and the overall set-up for in-vitro microscopy of the cremaster muscle. Scale bars are 0.25 cm.

    In some mice, a large vessel connects these organs to the muscle. In these mice, this vessel and tissues should be left connected but secured out of the viewing field to avoid dramatic tissue damage and blood flow anomalies.

  15. Spread the muscle across the silicone stage centered over the quartz pedestal and pin it along its periphery (Figure 4B).

  16. Transfer the platform and secured mouse to the microscope for visualization (Figure 4C, ​,DD).

  17. Identify target fields containing post-capillary venules that have normal flow using brightfield illumination. Ideal fields are those containing a relatively straight 30–50 μm post capillary venule with robust steady flow that does not pause or slow. Ideal vessels (under control conditions) will likely have rolling leukocytes and some arrested leukocytes. There should be several suitable fields available, representative regions are best identified by scanning several regions of the tissue Vessels closer to the surface will provide higher quality images.

  18. Record desired image sequences.

Image acquisition

  1. Collect the following image series as needed for the experiment:

  2. In brightfield, acquire 1 plane for 1 min at max speed to confirm flow.

  3. In fluorescence, acquire a z-stack through entire field with 1 μm step size to document the entire field. Note: Unlike z stacks of fixed objects where the entire stack is first acquired in one color, then a second stack in a second color, etc., to best visualize the temporal and spatial relationships of cells to vessels, it is best to take an image in each color at each z-plane. This results in slower acquisition of the entire stack, but truer anatomic relationships.

  4. Turn the contrast settings up while shortening the acquisition time to the shortest reasonable time (60–80 ms works well). Find a viewing plane with the vessel both centered on your screen and near the top of the viewing plane where adherent leukocytes can be seen. Record one plane in the leukocyte channel at max speed for 1 min to document rolling flux and adhesion.

    Turning up the contrast settings will cause the cells in the focal plane to be saturated. However, doing so allows for the visualization of many more cells outside the focal plane. Additionally, these shifted settings can allow for acquisition and counting of non-adherent cells passing in the bloodstream.

  5. Restore the settings back to those reasonable for long-term acquisition. Ideal settings will minimize both intensity and exposure time, which will help reduce photobleaching while allowing for maximum acquisition rate (frames per minute).

  6. Define the upper and lower boundaries for the vessel that is to be imaged longitudinally.

    Most of the TEM observed occurs on the sides of the vessel so be sure to include those regions within the z boundaries. Try to adjust the settings (exposure time, number of channels, number of z planes) so that an entire stack can be acquired in 15 s or less, which permits a frame rate of 4 per second If the timing allows, it is often beneficial to image more planes in the z direction so that the entirety of the vessel will still be captured even if there are subtle movements of the vessel over time.

  7. Check the mouse to determine if it needs a booster dose of anesthesia and administer if necessary.

  8. Check perfusion buffer to make sure there is enough to complete the recording (typically 15 min).

  9. Begin the longitudinal acquisition. Monitor the images in real time in order to adjust the focal plane as needed so that the desired vessel is always collected. Example acquisition of transendothelial migration in the cremaster is shown in Figure 5.

    Open in a separate window

    Figure 5.

    Example image of intravital microscopy of the inflamed cremaster muscle. Endothelial cell junctions labeled by PECAM (green) with red neutrophils and blue calcium signaling. Scale bars are 50 μm.

  10. In fluorescence, acquire a z-stack through entire field with 1 μm step size to document the entire field at the end of the imaging.

  11. After recording, examine the field again using brightfield illumination and acquire 1 plane for 1 min at max speed to check for any undesired changes in flow rate.. Do not score any field in which the flow has slowed dramatically or is stopped.

  12. If desired, find another field and repeat these steps.

  13. Sacrifice the mouse after the last images have been acquired.

Image analysis

  1. Open the image in the desired image analysis program.

  2. Confirm that the scale and time has been transferred or retained faithfully.

  3. Adherent cells may be counted by examining individual leukocytes along the vessel and assessing their movement over the 60 s recording. Adherent cells are defined as remaining attached and moving less than one cell diameter over 30 s. Vessel walls may be confirmed and measured with the thick stack acquired above. The vessel length is measured along the middle and average diameter averaged from multiple measurements along the length. Surface area (SA) can by calculated by modeling the vessel as half a cylinder with the equation SA=πrl+πr2; where l is the length and r is the average radius. The equation is for half a cylinder because the blood flow typically obscures the lower side of the vessel making it impossible to gather data from half of the venule.

  4. Determine the rolling flux by identifying a position in the vessel where rolling and free flowing leukocytes can be easily seen both in and out of focus and count the number of leukocytes that roll past this point over the recording. Data are expressed either as number of rollers (past this point) per second or per minute.

  5. Rolling flux fraction can be calculated by counting the number of leukocytes that pass the same point in the blood stream. Leukocytes in the blood stream will appear as streaks and should be able to be tracked in sequential frames.

    It may not be possible to do this calculation in vessels with fast flow as it requires the confident identification of free-flowing cells in multiple frames. Likewise, if the leukocyte marker is not bright enough, free flowing cells may not be detected with high enough confidence to make an accurate calculation. To acquire images more rapidly and capture free flowing leukocytes in a fast stream, try decreasing the exposure time and increasing the laser/light power and artificial signal enhancements (i.e. sensitivity and gain). Also, smaller venules usually have slower blood flow so consider changing fields.

  6. Transendothelial migration is quantified from the long recording by tracking individual cells as the move over time. Typically, cells will adhere and/or roll into the view and spend a few minutes crawling around, usually along endothelial junctions (identified by staining with the anti-PECAM 390 antibody). When they undergo TEM, they will stop moving and ‘ball up’. Shortly thereafter they will be observed dramatically flattened and on the outside of the vessel.

    This entire step is often quite quick and may only appear in two or three frames. Thus, one can infer transendothelial migration by the simultaneous change in morphology and position. Depending on the location on the vessel, this step may correspond to a detectable hole in the PECAM junctional staining. This pore is usually more noticeable (i.e. more easily resolved) when the event occurs at or near the top of the vessel. Lower z-axis resolution often obscures clear pore formation. After flattening on the outside of the vessel, the leukocyte will often linger for several minutes before detaching and migrating several microns away from the vessel.

SUPPORT PROTOCOL 2:

Making a silicone stage

The cremaster muscle is uniquely useful in imaging inflammation and extravasation from systemic vasculature due to its thin, vascularized structure. To effectively image this membranous muscle with confocal and/or brightfield microscopy, the cremaster muscle must be exteriorized onto an imaging stage that is conducive to microscopy and capable of keeping the structure exposed and still. The use of a quartz viewing stage surrounded by silicone allows the tacking of the cremaster muscle and exposure of vasculature of interest. Here we describe the use of quartz, which is a stable, optically clear, and predictable viewing platform critical for the use of microscopy.

Materials:

Starting materials:

SYLGARD 184 Silicone Elastomer Kit (Dow Corning # 4019862)

Clear fused quartz ground and polished disc, 1×0.25in (Technical Glass Products #1X0.25)

6-well tissue culture dish

Modeling clay

Hardware and instruments:

Vacuum chamber

Dissecting light

Protocol steps with step annotations:

  1. Mix silicone reagents A and B according to manufacturer’s directions in 1:10 proportions.

  2. Place the quartz disc with a flat side facing down and up in one well of a 6-well tissue culture dish.

  3. Pour the silicone reagents into the well, surrounding the quartz, until the meniscus of the silicone is flush with the top surface of the quartz (Figure 6).

    Open in a separate window

    Figure 6.

    Schematic of silicone stage with embedded quartz pedestal (left) and its cross-section (right).

  4. Place the tissue culture dish in a vacuum chamber.

  5. Leave under direct light overnight at room temperature.

  6. Remove the silicone embedded quartz stage from the dish.

  7. Silicone embedded quartz stages last approximately 20 surgeries before the silicone loses its structural integrity. Rinsing with water is adequate to clean the stage. The quartz can be removed from the silicone using a blade and reused.

Commentary:

Background information

Intravital microscopy of the cremaster muscle has been integral in the discovery and further study of the inflammatory cascade, the process by which inflammatory cells migrate to sites of inflammation. It is a site by which the mechanisms of migration of leukocytes in the systemic vasculature have been interrogated and is an ideal place to study inflammation. This protocol is advantageous in that the cremaster muscle is easily accessible with minor surgery and is transparent enough to be imaged with ease. The results of this protocol can be used to interrogate the response of leukocytes to inflammatory stimuli, blockades and treatments, and various interventions relevant to inflammation in the systemic circulation.

Critical parameters:

Ideal Fields

One of the best ways to ensure consistent results and striking movies is to pick consistent fields to observe and record. The ideal venule will:

  1. be largely straight and not tortuous for at least 150 μm in length,

  2. be 30–50 μm in diameter,

  3. be near the surface/closer to the objective,

  4. have consistent flow without any pulsating or occasional pausing, and

  5. have signs of inflammation including adherent and rolling leukocytes and some leukocytes already out in tissue.

Although it is common to have to compromise on some these details, it is important to understand how they may affect the results. It is difficult to measure velocities in tortuous vessels and they often have abnormally high adhesion. Narrower vessels and vessels with inconsistent flow usually have slower flow rates and often dramatically increased adhesion and slower rolling. In addition, vessels with intermittent flow will often cease flowing by the end of the recording, making the entire effort fruitless. Signs of active inflammation is often a good indicator of ongoing recruitment and TEM. However, one must be careful not to bias the results by only choosing ‘hot’ areas. In almost every mouse, there are regions of hyper- and hypo-inflammation, possibly due to damage during tissue preparation or exposure to the stimulus. Where rolling and adhesion are to be examined, it is more important to compare vessels of similar size and tortuosity. Where TEM is to be examined, extra attention should be given to finding venules that have a modest amount of active inflammation, to avoid hyperactive areas (obviously little TEM can occur where there is no rolling or adhesion.)

Drifting field and tenting

It is somewhat common for the field to drift (move in x and y) slightly over the course of the recording due to changes in the muscle tension and relaxation. Small drifts can be corrected in the image processing software to align the images together. If given the option, align the time points according to the vessel fluorescence channel, because the structures are more consistent than the leukocyte channel. If the field moves too much, longer recordings may become impossible. Typically, fields are more stable at the periphery of the tissue near where it has been pinned. Unfortunately, these regions are less likely to have appropriate venules to record. Drifting can be limited somewhat by using more pins to secure the tissue, especially proximal to the body. Take care when adding pins in this region though, it is easy to apply too much tension to the major vessels that feed and drain tissue thus affecting the flow rates to the entire tissue. Another common issue is tenting or drifting in the z direction. This occurs when fluid slowly accumulates under the tissue pushing it up and moving it out of focus. Slow changes can be corrected for by adjusting the z-focus manually (if the scope allows). Tenting can typically be avoided by making sure that the tissue exits the body parallel to the silicone mount and pedestal, and that it is well secured. Keeping the flow rate of the perfusion buffer slow but steady will help keep it from accumulating beneath the tissue.

Tissue drying out

Typical recordings of TEM can go for 15 minutes or longer. During this time, the perfusion buffer running down the objective will hydrate the field of view. However, depending on subtleties of the tissue and silicone support, the distal regions of the tissue may not receive adequate flow to remain viable. After finding a view of interest, take note of the hydration state distal regions of the tissue to make sure they are receiving enough buffer to remain hydrated. Ideally, much of the tissue will be clearly covered with buffer. To prevent the tissue from drying out and ruining potentially ideal fields, the flow rate of the perfusion buffer can be increased. This issue is more common for regions visualized near the periphery and less so in nearer the center of the tissue. If this is not possible alter the flow rate or change positions, the tissue may be hydrated manually by gently pipetting a small amount of warm perfusion buffer directly onto the tissue. Take care to apply it between images and avoid touching the lens or tissue.

Fluorescent mice

To avoid the use of labeling antibodies that might interfere with leukocyte or endothelial cell function, it is often easiest to use mice that express fluorescent proteins in the specific subset of leukocyte one wishes to observe. For example, GFP inserted into the LysM locus adequately labels all myelomonocytic cells (neutrophils, monocytes, and macrophages), although neutrophils are typically brighter than monocytes while macrophages are somewhat dim, more ramified, and within the tissue rather than intravascular. Along these lines, it is possible (and convenient) to use mice whose leukocytes have been rendered fluorescent. Mice with genetically encoded fluorescent leukocytes are available with virtually any leukocyte subtype labeled. These can be bred to your mouse of interest or, assuming histocompatability, provided via a standard adoptive bone marrow transfer.

Troubleshooting

Table 2 lists problems that may arise with the procedures for intravital microscopy of mouse cremaster muscle, along with their possible causes and solutions.

Table 2.

Troubleshooting Guide for Intravital Microscopy of Mouse Cremaster Muscle

ProblemPossible CauseSolution
Poor signalFocal plane is too deepFind a field closer to the surface
The labeling method was not effectiveInject more labeling antibody i.v.
Poor flowVessel is constricted or clottedFollow the venule back to a rapidly flowing region and the examine the vascular tree to find a region with adequate flow
Vascular bed/area has been compromisedCheck a distal region
Tissue has dried outNot enough perfusion buffer reaching the regionIncrease the perfusion buffer flow rate and/or manually hydrate the tissue
Field of view is drifting in x or yTissue relaxation or constrictionImage areas closer to the periphery
Field of view is drifting in z, tentingPerfusion buffer is accumulating under the tissueSecure the tissue with more pins proximal to the body and/or image closer to the periphery

Open in a separate window

Understanding results

The image series collected as described here will allow the investigator to carefully compare various components of the leukocyte adhesion and diapedesis pathway. Because of the sequential nature of this process, it is common that one component will be affected while the other components remain relatively unchanged. For example, disrupting the diapedesis step will typically not alter the ability of the leukocytes to roll or adhere to the vessel wall and thus the measured rolling velocity and the number leukocytes per field would remain similar controls. However, disrupting diapedesis will likely lead to more leukocytes found inside the vessel lumen (because they are unable to migrate out). Likewise, disrupting adhesion would reduce the total number of leukocytes observed on the vessel wall and, because it downstream, the total number of leukocytes found in tissue. In this case however, the diapedesis of those leukocytes that do adhere would likely be rapid and robust. Only by recording the multiple components of the pathway is it possible to identify which processes are fundamentally affected. Upon successful acquisition of the suggested image series, the investigator will have high quality images detailing leukocyte rolling, adhesion, diapedesis and migration through the tissue.

Time considerations

When deciding the timing, take into consideration the experience level of the surgeon and the microscopist. An experienced technician can perform the entire surgery (from anesthetizing the mouse to tissue ready to image) in about 30 minutes. Likewise, setting up the microscope, finding a field, and beginning the TEM recording need not take more than 15 minutes. Less experienced personnel may take two or three times as long. Ideally, one would plan to begin recording just before the peak inflammation time, just at the start of the biologically relevant window (i.e. at 4 hours post stimulus injection for neutrophils.)

Care must be taken when determining when to exteriorize the tissue to ensure one is within the correct biological window. Neutrophils are typically the early responders with egress peaking 4–8 hours after the injection of stimulus while monocytes typical peak around 24 hours. The ideal time point can be determined for a particular mouse strain and stimulus combination by using a time course and simply harvesting the tissue to check the progress.

BASIC PROTOCOL 3:

Wide-field microscopy of the mouse brain

Wide-field imaging allows for the rapid acquisition of images over an entire field. Unlike confocal imaging, wide-field imaging has limited resolution in the z axis, making it difficult to delineate whether a particular leukocyte has extravasated outside of a vessel. However, in contrast to confocal imaging, wide-field imaging allows for the visualization of global leukocyte migration patterns. In this protocol, wide-field microscopy is used to visualize leukocytes in relation to the vasculature across an entire fluorescently labeled brain slice. This protocol provides advice on how to remove the brain and image with wide-field microscopy to quantify leukocyte extravasation. Here we provide an outline to quantify transmigration in the brain vasculature.

Materials:

Starting materials:

Genetically modified mice with fluorescent leukocytes, such as LysMGFP, CatchupIVM or Ccr2RFP mice

Anti-PECAM antibody conjugated to a fluorophore (EMD Millipore,CBL1337 clone 390, Rat anti-mouse, non-blocking)

DPBS, 1X without calcium & magnesium (CORNING, lot 26321007)

4% paraformaldehyde solution (see recipe in Reagents and Solutions)

Hardware and Instruments:

30 mL syringes

Fine forceps and scissors

Dissecting pins

Razors

Murine Brain Matrix (RWD; device for holding brain in place for precise slicing)

Coverslip dishes (Mattek with #1.5 coverslips)

Wide-field microscope (Nikon or equivalent) with 4X objective

Protocol steps with step annotations:

  1. Inject 100 μg of fluorescently conjugated anti-PECAM antibody (clone 390) into the mouse intravascularly (i.v.) to label the vasculature.

  2. Wait 30 minutes.

  3. Sacrifice the mouse with CO2 based on the euthanasia guidelines for rodents.

  4. Conduct thoracotomy and transcardial perfusion through the left ventricle with 30 mL of PBS until the blood is cleared as previously described (Wu et al., 2021).

    Well-perfused mice will have a blanched liver. Poorly perfused mice may have leukocytes that will interfere with the determination of leukocyte position in relationship to the blood vasculature.

  5. Decapitate mice, cut the skin and secure the head with dissecting pins (Figure 7).

    Open in a separate window

    Figure 7.

    Schematic diagram depicting mouse brain removal. (A-B) Skin is cut to expose the skull and pinned to the dissection board to secure the head. (C) The skull is scored along the midline. (D-F) The skull is removed with forceps to expose the brain underneath. (G) The brain is placed into the murine brain matrix and cut into 2 mm sections using single edged razor blades.

  6. Score the skull along the brain midline with a razor. Gently score the skull to avoid damaging the brain underneath.

  7. Gently remove the skull with forceps. Gently remove the skull to avoid damaging the brain underneath. Meninges that remain attached to the brain surface may also be removed.

  8. Remove the brain, place the brain into the murine brain matrix (RWD) and cut the brain into 2 mm sections using single edged razor blades.

    Place the murine brain matrix and razor blades on a paper towel on ice to cool the equipment to preserve the brain. Note that the brain can be cut into 1 mm intervals, but fresh razor blades must be used to ensure the slices remain intact and do not break apart. To help maintain the proper anatomy during slicing, place each razor blade in succession into the brain until it just engages the slots of the matrix. When all razor blades are in place, push down evenly on all of them at the same time.

  9. Incubate the brain slices in 4% paraformaldehyde for at least 2 hours. Incubation times depend on the thickness of the brain intervals. Longer times may quench fluorescence signal.

  10. Place the brain slices on coverslip dishes (e.g. Mattek with #1.5 coverslips).

  11. Image the brain from below using a Nikon Eclipse Ti2 wide-field microscope with a Nikon 4x objective (0.20 NA) equipped with a Nikon DS-Qi2 camera.

  12. Collect images over the entire slice with a 15% overlap. Stitch the images together using the embedded stitching algorithm of NIS elements (Nikon, version 5.11.01) with the Optimal Path option.

Background Information:

This protocol is useful for visualizing the position and density of infiltrating leukocytes and can be used to generate a cohesive unbiased spatiotemporal image of leukocyte infiltration in the brain. Generating a spatiotemporal image of infiltrating leukocytes is helpful for understanding leukocyte migration patterns in various diseases and the global effects of therapeutic agents on leukocyte distribution in the brain.

Critical parameters:

It is important to consistently prepare the samples for imaging. Since blood contains leukocytes that have not adhered to endothelial cells, inconsistent perfusion may affect the number of leukocytes quantified by this method. Additionally, paraformaldehyde has been shown to quench some fluorescent molecules. Therefore, samples should not be over-fixed to preserve fluorescence.

Troubleshooting:

Table 3 lists problems that may arise with the procedure for wide-field microscopy of the murine brain, along with their possible causes and solutions.

Table 3.

Troubleshooting Guide for Wide-field Microscopy of the Murine Brain

ProblemPossible CauseSolution
High BackgroundBrain slice may be too thick, increasing background, particularly in the GFP channel.Cut the brain into 1 mm intervals to decrease the background signal.
Debris in the sectionDebris in the murine brain matrixClean the murine brain matrix after every use to limit debris. Debris can also be removed from the sections under a dissecting microscope.
Weak FluorescenceCells are over fixedReduce the incubation time in 4% paraformaldehyde

Open in a separate window

Understanding results:

Wide-field imaging is useful due to the ability to acquire images over a large field. Processing and segmenting the image allows for quantification of the total number of leukocytes that have migrated into a field and visualization of leukocyte migration patterns in relation to areas of injury and major structures. The manner one would use to present the data depends on the research question, as wide-field imaging is useful to characterize the leukocyte migration patterns. For example, one could use this technique to quantify the number of leukocytes that have migrated into an ischemic region surrounding an infarct in comparison to the area that surrounds the infarct.

Time considerations:

Preparation for imaging will take approximately 2.5 hours. Imaging may take 10–30 minutes, depending on the size of the field, the number of channels used, and the microscope objective (we recommend a 4x objective, but other objectives may be used).

BASIC PROTOCOL 4:

Imaging the Lungs (Ex Vivo)

Imaging the vasculature of the lungs can be challenging because of the dense capillary network surrounding the alveolar sacs of the lungs. The vasculature of the lungs is unique from any other tissue, and inflammation in the lungs underlies many pathologies. These methods are used for imaging inflammation in the lungs after induction of injury or at baseline physiological conditions. These protocols can be used to prepare lungs to image leukocyte extravasation by widefield microscopy or any type of fluorescence microscopy. Here we provide an outline to image inflammation in the murine lung. This protocol includes two experimental techniques for inflating the lungs. One protocol involves inflation via tracheostomy while the other utilizes a long, blunted gavage needle to inflate the lungs. The experimenter can choose whichever method they feel most comfortable executing, as the end-result will be identical.

Materials:

Starting materials:

Avertin (see recipe in Reagents and Solutions)

70% ethanol

4% paraformaldehyde fixing solution (see recipe in Reagents and Solutions)

Sucrose

DPBS, 1x, without calcium & magnesium (Corning, #26321007)

OCT Compound (Sakura #4583)

Dry ice

Hardware and Instruments:

Dissecting board

Dissecting tools

Dissecting board pins

Sutures

1mL syringe

Luer stubs (Instech Labs #LS20)

Dissecting scope

MatTek dishes (MatTek #P35G-1.5–14-C)

Tissue-Tek Cryomold 15×15×5mm (Fisher Scientific, #NC9511236)

22×22mm cover slips (Fisher Scientific, #50-143-780)

Razor blades

Cryostat blades

Brush

Slides

Cryostat for tissue sectioning

Widefield microscope

FIJI software

Optional materials:

Labeling antibodies (e.g. 390 to label endothelial cell junctions)

Brain matrix (RWD)

Please see Figure 8 for a general workflow for imaging the lungs ex vivo, the details of which are described below.

Open in a separate window

Figure 8.

Standard workflow for lung removal and imaging.

Protocol steps with step annotations:

Removing the lungs:

  1. Induce inflammation or perform the procedure necessitated by the experiment along with any appropriate controls.

  2. Prior to euthanization, inject any needed live antibody labels. Make sure that these are fixable.

    Typically, 30 minutes prior to euthanasia, we label PECAM-1 with non-blocking 390 antibody and 2,000,000MW dextran.

  3. Inject the mouse with an overdose injection of Avertin (800ul-1ml of Avertin, prepared as noted previously) to achieve deep anesthesia.

    This can be performed by any IACUC accepted procedure, however because many anesthesia methods are inhaled, you must be mindful of potential for your method to cause further damage/inflammation in the lungs.

  4. Once the mouse is in a deep plane of anesthesia (unresponsive to toe pinch), you can proceed with the lung removal.

  5. To remove the lungs, place the mouse flat on a dissecting board on its back, pinning all four limbs to the board using pins.

  6. Use 70% ethanol to wet the hair on the top of the mouse, focusing on the abdomen and the head. This is not to sanitize or clean the mouse but rather for fur control (to avoid getting fur in the sample).

  7. Gross dissect the skin away from the abdomen by gently pulling up on the skin on the abdomen with blunt forceps and making a small incision with blunt-tipped scissors. Insert the scissors in the cut, below the skin but above the chest plate. Open and close the scissors, gently moving them up the abdomen until you’ve bluntly dissected the skin away from the chest plate up to the jaw.

  8. Using the blunt tipped scissors, cut away the loose skin covering the chest and bottom of the jaw.

  9. Underneath the jaw of the mouse, there will be two pieces of white-pink tissue (salivary glands). Pull these two apart or remove them completely, exposing the trachea.

  10. Remove the chest wall by cutting away the diaphragm and up the left and right side of the ribs. This will expose the lungs.

  11. Carefully dissect away the protective tissue around the trachea, exposing the horizontal rings of cartilage. You should dissect away the tissue both ventrally and dorsally.

  12. Thread a 10cm piece of suture under the trachea, leaving equal visible trachea space above and below the suture.

  13. Using small, sharp scissors, make a small (~1mm) cut in between the rings of cartilage of the trachea.

    To make this easier, you can gently tug up on the suture, pulling up and exposing more of the trachea from the body. However, you want the trachea to remain in one piece connected to the lungs.

  14. Insert the Luer stub into the incision and tightly tie the suture around the Luer stub and trachea with a single square knot that can be undone.

  15. Slowly instill the lung with up to 700ul of fixative using a 1ml slip tip syringe.

    The volume of murine lungs is approximately 1ml, depending on the size of the mouse. You want to inflate the lungs to retain the integrity of the alveolar structure, but not overinflate them. We fix with 4% PFA.

  16. Remove the syringe and Luer stub while simultaneously tightening the suture to keep the fixative inside the lungs. Tie off the suture with a box knot.

  17. Holding the trachea up with the suture (gently pulling away from the body), cut at the top of the trachea, then dissect the lungs and heart away from the body.

  18. Remove the lungs/heart together with the suture. Place in a container filled with fixative.

  19. At this point, you can either quick-fix or fully fix. If you are quick-fixing, leave the lungs in the fixative for 30 minutes then move to imaging. If you are fully fixing, leave in fixative overnight. The next day, transfer the lung to 15% sucrose in PBS. Once the lungs have sunk to the bottom in the 15% sucrose (usually 1–2 days), transfer them to 30% sucrose until they sink (1–2 days).

  20. Once the lungs are ready for imaging, you can image whole lungs, thick sections, or thin sections. You can also split the lungs up into left and right lungs or individual lobes for different imaging methods.

    For confocal imaging, we typically use whole lung lobes. For widefield or epifluorescence, we typically use thick or thin sections.

For whole lung imaging:

  1. Remove the lungs from fixative. Dissect away any blood clots or excess tissue from the outside of the lungs.

  2. Using sharp scissors, cut off the whole lobe that you plan to image. Be careful to not cause any trauma on the outside of the lungs. This can be ensured by holding the heart with forceps rather than the lung itself.

  3. Under the dissecting microscope, pop any surface bubbles and clear the top of the lobe of blood and tissue as much as possible. Bubbles will continue to rise to the surface as a result of the physiology of the lung, just do your best to pop surface bubbles.

  4. Place the lobe, viewing side down, in a MatTek dish. Hydrate with PBS and place a cover slip on top.

  5. The lung is now prepared for imaging.

For thick sectioning:

  1. Remove the lungs from fixative. Dissect away any blood clots or excess tissue from the outside of the lungs.

  2. Using sharp scissors, cut off the whole lobe that you plan to image.

  3. Place the lobe in a Tissue-Tek Cryomold and either quick or slow freeze the lobe. To quick-freeze the lobe, place the cryomold on dry ice (5–10 minute). To slowly freeze the lobe, place the cryomold in a −20C freezer until frozen (30–60mins).

  4. Remove the lobe and section in 1mm slices with a razor blade. This can be done by eye or in a brain matrix for sectioning. Using a brain matrix works best on the left lobe of the mouse.

  5. Place the section in a MatTek dish in 3–4 drops of PBS. Under dissecting microscope, pop any surface bubbles and place a cover slip on top.

  6. The lung is now prepared for imaging.

For thin sectioning:

  1. Remove the lungs from fixative. Dissect away any blood clots or excess tissue from the outside of the lungs.

  2. Using sharp scissors, cut off the whole lobe that you plan to image.

  3. Place a dot of OCT in a 15×15×5mm Tissue-Tek Cryomold. Wait until the OCT has settled at the bottom, and all bubbles have popped. The OCT should fully coat the bottom of the Cryomold.

  4. Place the lung lobe you plan to image on the OCT in the cryomold. Cover the lung with more OCT until it is fully submerged. Allow the OCT to settle and all the bubbles to pop (2–3 mins).

  5. Place the cryomold on dry ice.

  6. Once frozen, remove the frozen block from the mold and place inside a cryostat set to 18C.

  7. With a razor blade, cut off the edges of the OCT that don’t contain lung tissue.

  8. Using the Cryostat, section the lung tissue into 10–15um sections and place on a slide. Keep the slides uncovered on dry ice.

  9. Rinse the OCT off by placing 2–3 drops of PBS on the slide for 5 minutes before placing a cover slip on the slide.

  10. The slides are now ready to image.

Counting Cells in FIJI

  1. Import your image into FIJI using the BioFormats importer.

    If this has not been previously installed, go to Downloads, Show Contents, and paste BioFormats into the plugin folder.

  2. Split any color channels into their own separate image tabs by going to: Image, Color, Split Channels.

  3. For each color channel with cells, perform background subtraction based on pixel size. Select Process, Subtract Background, and input the approximate pixel size of the cell type for the background subtraction.

    Pixel size will differ based on the magnification, cell type, and/or microscope. Utilize scale bars based on the microscope/objective you’re using to estimate pixel size.

  4. To count the cells in a given channel, convert the channel to a binary. Select Process, Binary, Make Binary. Select Analyze, Analyze Particles…, and input your criteria. The Analyze Particles function can discriminate on the basis of size and circularity. This will differ depending on your cell type (Figure 10).

    Open in a separate window

    Figure 10.

    Automated counting of neutrophils using particle analysis in FIJI.

  5. This will open the ROI Manager which will contain the results of your count. This can be used as your final count.

ALTERNATE PROTOCOL 4:

Inflating the Lungs Without Tracheostomy

Introduction:

The gavage device is reusable and runs less risk of fully tearing the trachea and being unable to tie the suture. This alternative protocol may also be easier for someone newer to the technique.

Additional Materials:

Straight Stainless Steel Olive Tip Cannula with Leur Lock Base

Protocol with step annotations:

  1. Attach a straight stainless steel olive tip cannula with a Leur Lock base to a 1 – 5 ml syringe containing fixative.

    These cannulas are available from a number of medical supply companies in a variety of gauges. Select one with a tip diameter appropriate for the size of the mice you will use to avoid overstretching the trachea.

  2. Gently insert the cannula through the oropharynx into the trachea. It is helpful to pull up on the mouse’s lower jaw with forceps to help guide it. The trachea is anterior to the esophagus, so guide the cannula pushing it slightly anteriorly and caudally to avoid insertion into the esophagus.

  3. You will see the tip of the cannula enter the trachea through the cartilage rings. When it is more than halfway to the lungs, thread a piece of suture behind the esophagus and tie the first half of a square not around the trachea, holding the cannula in place.

    The membrane on the posterior side of the trachea has no cartilage; it is very thin and delicate, so it is better not to try to dissect it away from the esophagus. The esophagus can always be dissected off the specimen later, if necessary, and will be easier to accomplish once the tissues are fixed.

  4. Slowly instill the lung with up to 700ul of fixative using a 1ml slip tip syringe.

    The volume of murine lungs is approximately 1ml, depending on the size of the mouse. You want to inflate the lungs to retain the integrity of the alveolar structure, but not overinflate them. We fix with 4% PFA.

  5. Remove the cannula from the trachea while simultaneously tying the second half of the square not tightly around the trachea to prevent the fixative from leaking out.

Commentary:

Background information

This technique is advantageous in that the preparation of the lungs for imaging is flexible. If necessary, the protocol can be done quickly, and the tissue can be prepared and serially sectioned. This is particularly useful if the fluorophore being used is easily quenchable. If a longer fixation is more beneficial to the final imaging product, this can also be done. This method also allows mixed use of protocols, i.e. you can use different methods for the different lobes of the murine lung. This protocol is useful for determining whether your stimulus or intervention results in the induction of inflammatory cells in the pulmonary vasculature. It is also useful for determining the degree to which varying stimuli induce inflammatory cell infiltration.

Critical Parameters:

In this protocol, it is important that you remove the lungs carefully. Mishandling during removal can cause damage to the tissue. Additionally, it is important that the section you are imaging is the section that you are interested in. Because the physiology of the lungs can vary from the surface to the deepest parts of the organ, it can be useful to serially section (either thin or thick) and image a number of different sections to validate results as being consistent throughout the tissue.

Troubleshooting:

Table 4 lists problems that may arise with the procedures for imaging inflammation in the murine lungs ex vivo, along with their possible causes and solutions.

Table 4.

Troubleshooting Guide for Imaging inflammation in the murine lungs (ex-vivo)

ProblemPossible CauseSolution
High BackgroundLung slice may be too thickOpt to use thin sectioning rather than thick sectioning
BubblesBubbles in the image during microscopyAfter placing the lung section in a MatTek dish, place under dissecting microscope. Gently disperse as many bubbles as possible and image ASAP.
Weak FluorescenceCells are over fixedReduce the incubation time in 4% paraformaldehyde
Inflammation in controlsEuthanasia method is inducing inflammationOpt for an overdose of a drug like Avertin as opposed to CO2 asphyxiation

Open in a separate window

Understanding Results:

Analyzing and interpreting the results of this protocol will vary based on the type of label used for the fluorescent tagging of leukocytes and/or blood vessels. After completion of imaging, you should have labeled vasculature with the presence of leukocytes in the appropriate fluorescent channel that corresponds to the fluorescent tag used. As shown in Figure 9, you should see the presence of small round leukocytes in the vasculature of the lungs (marked by its alveolar shaping).

Open in a separate window

Figure 9.

Inflammation in the lungs. Neutrophils (orange) infiltrated the pulmonary vasculature (red) during acute inflammation. 40x, widefield. Scale bars are 250 μm.

Time Considerations

The time from induction of inflammation to imaging depends on the model. After the euthanasia of the mouse, the protocol should take 2–3 hours if quick-fixing or 24–72 hours if undergoing a lengthier fixation process. The length of the fix is the main determinant of time.

BASIC PROTOCOL 5

Inducing, Imaging, and Quantifying Infiltration of Leukocytes in Mouse Retina

The objective of basic protocol 5 is to be able to induce, image, and quantify leukocyte extravasation from vasculature in mouse retina. The eye is an immune-privileged organ and has few leukocytes at baseline; thus, to visualize leukocyte infiltration, the experimenter will need to use a stimulus to induce inflammation in the eye. This can be done by intravitreal injection of an inflammatory stimulus prior to sacrifice. The experimenter will then conduct immunofluorescence staining on wholemount retina and acquire fluorescent images to visualize the leukocytes and retina vasculature. The experimenter can use FIJI to process the immunofluorescence images and quantify leukocyte extravasation. If the protocol is conducted properly, the experimenter will induce inflammation, visualize, and quantify leukocyte infiltration in the mouse retina.

Materials:

Starting materials:

Ketamine/Xylazine concoction (see recipes in Reagents and Solutions)

Ketamine hydrochloride (Covetrus, NDC# 11695-0703-1)

Xylazine (Akorn Inc., NDC# 59399-110-20)

Proparacaine hydrochloride eye drops

Phenylephrine hydrochloride eye drops

Tropicamide eyedrops

DPBS, 1X without calcium & magnesium (CORNING, lot 26321007)

4% paraformaldehyde fixing solution (see recipe in Reagents and Solutions)

Blocking solution (see recipe in Reagents and Solutions)

Washing solution (see recipe in Reagents and Solutions)

ProLong Gold Antifade Mountant (Thermo Fisher; catalog # P36930)

Recombinant Mouse CCL2/JE/MCP-1 Protein (R&D Systems Incl; catalog # 479-JE-050/CF)

Rabbit Anti-S100A9 antibody [2B10] (Abcam; ab105472) to detect neutrophils

Rabbit Anti-IBA1 antibody (Wako, 019–19741) to detect macrophages

Goat Anti-Collagen IV antibody (Abcam; ab19808) to detect vessels

Goat Anti-CD31 antibody (R&D Systems, AF3628) to detect vessels

AffiniPure Goat Anti-Rat IgG (Jackson; Lot # 112-005-167) – conjugated in house

Alexa Fluor® 647 AffiniPure Goat Anti-Rabbit IgG (Jackson; Lot # 111-605-144)

Hardware and Instruments:

Ear punch tool

Scale

1 mL syringe

30G needle

5 mL syringe

Scissors

Model 901 Removable Needle Syringe, 10 μL capacity (Hamilton, Ref # 7648–01)

Small Hub Removable Needle, 32 gauge, 0.4 inch, point style 3 (Hamilton, Ref # 7803–04)

CO2 tank with mouse euthanasia apparatus

Carcass disposal bag

Curved forceps (Fine Science Tools; No. 91117–10)

Light microscope

Ring forceps (Fine Science Tools; No. 11103–09)

Spring scissors (Fine Science Tools; No. 15003–08)

Straight forceps (x2; Fine Science Tools; No. 11254–20)

Weigh boats

12-well plates (Thermo Scientific; Catalog # 130185)

24-well plates (Thermo Scientific; Catalog # 130186)

Orbital shaker

3 mL transfer pipettes (VWR; catalog # 52947–948)

3” × 1” × 1.2 mm microscope slides (VWR; catalog # 16004–370)

20 × 60 mm, #1.5 microscope cover glasses (VWR; catalog # 16004–312)

Stirring hotplate (Thermo Fisher; catalog # SP88854100)

Protocol steps with step annotations:

Tagging and Sedating Mice

  1. Obtain mice of interest, such as C57BL/6 or Ccr2RFPCx3cr1GFP mice.

  2. If using multiple mice, tag to differentiate one from another. Suggestions for tagging include ear punch or ear tag.

  3. Weigh mice.

  4. Calculate dose of ketamine/xylazine to administer to mice based on weight. See for more information on ketamine/xylazine concoction.

  5. Scruff mice and inject correct ketamine/xylazine dose intraperitoneally. Wait a few minutes until mouse is sedated.

    Mouse is sedated enough for intravitreal injections once it is immobile and its whiskers are minimally twitching.

    If mouse is not sedated enough with initial dose, boost with 25–50% of initial ketamine/xylazine injection.

    CAUTION: Injecting too much ketamine/xylazine can kill the mouse. Be careful to inject the correct dose based on weight.

  6. Once mouse is sedated, inject 0.4 mL of meloxicam (1:100 meloxicam:1XDPBS mixture) subcutaneously with 30G needle attached to a 5 mL syringe. To perform a subcutaneous injection, place mouse on a flat surface, pinch and lift the skin on its back and inject into the lifted skin.

    Be sure the needle is just under the skin and not to push the needle through to the other side to prevent injury to self.

Intravitreal Injection of Inflammatory stimulus CCL2

  1. Trim whiskers to prevent microscope examination disruption.

  2. Scruff mouse and position its head with one eye facing up. Administer one drop of proparacaine hydrochloride to eye. Balance the drop for 2–3 seconds, then shake off. Repeat in other eye.

    Proparacaine hydrochloride is a topical anesthetic that will numb the eyes.

  3. Administer phenylephrine hydrochloride eye drops (same handling technique as in step 8).

    Phenylephrine hydrochloride will dilate the pupils and retract the top eyelid back.

  4. Administer tropicamide eye drops (same handling technique as in step 8).

    Tropicamide is an anti-cholinergic drug that will dilate the pupils.

  5. Place mouse under light microscope on a paper towel. Position the head with the eye of interest facing up.

    Note: Lubricate eyes with artificial tears every five minutes to prevent the corneal surface from drying out. Mice lose their blink reflex when sedated.

  6. With a 30G needle attached to an empty 1 mL syringe, make an incision just posterior to the sclerocorneal junction on the lateral side of the eye (Figure 11). The incision should be bevel deep and no more.

    Open in a separate window

    Figure 11.

    Schematic diagram of a mouse eye with the pupil, iris, cornea, and sclera labeled. The sclerocorneal junction, or limbus, is outlined in red, and the location for the initial incision prior to CCL2 injection is indicated with a blue star. The medial and lateral sides of the eye are also labeled; the incision should be done on the lateral side of the mouse eye. Created with BioRender.com.

    If the mouse’s eyelashes are obscuring your view of the globe, gently brush away the lashes with body of needle.

  7. With a Hamilton syringe loaded with your inflammatory stimulus (CCL2, 5 ng / uL), insert the tip of the needle two (2) millimeters deep into the incision you created in step 12. Have a second person help push the plunger to inject 1 uL of CCL2.

  8. Flip the mouse to its other side and repeat steps 11–13 to inject the other eye. Omit this step if you are only injecting one eye.

  9. Place mouse in an empty cage on a cage warmer until the mouse wakes up.

  10. Return mouse to its original cage and provide food and water as usual. Sacrifice mice to harvest eyes 24 hours after intravitreal injection.

    The amount of time to sacrifice is dependent on your experiment. 24 hours post-CCL2 injection is sufficient to visualize neutrophils and monocytes.

Enucleation and Dissection of Retina

  1. At the desired time after intravitreal injection, euthanize mice per IACUC protocol.

  2. Using curved forceps, enucleate the eyes: maneuver the forcep tips around and under the eye globe, pinch the optic nerve and gently pull the eye free from the socket (Figure 12). Place enucleated eyes in a dish with 1X DPBS and place under a dissecting light microscope.

    Open in a separate window

    Figure 12.

    Schematic diagram of a profile view of an eye. The eye globe and optic nerve are labeled. When enucleating the eye, it is important for the experimenter to pinch the optic nerve behind the globe and not the globe itself, as highlighted in the diagram (arrow). Created with BioRender.com.

  3. Dissect globe to remove conjunctiva, extraocular muscles, and orbital fat. Stabilize globe with ring forceps and make small incision (1 mm) with spring scissors at the limbus of the eye.

  4. Substitute ring forceps with straight forceps. Insert straight forcep tip into the incision from step 19 and grip the anterior portion of the eye.

  5. Cut along the limbus around the globe using spring scissors in one hand, while gripping the anterior portion of the globe using straight forceps with the other hand.

  6. Remove the anterior portion of the eye.

  7. Separate the lens from the posterior globe.

    If the lens is adhered to the posterior cup, use forceps to grab the choroid-sclera complex, optic nerve, or any tissue that is not the retina while coaxing the lens out with straight forceps in the other hand.

  8. Pinch the choroid-sclera complex with straight forceps in both hands and tear. Continue tearing at different parts of the globe until the cup is easily separable from the retina.

    Be careful not to pinch or touch the retina at any point as it is very fragile tissue.

  9. Pinch the retina at the optic nerve to separate it from the cup.

Immunofluorescent Staining of Wholemount Retina

Day 1
  1. Place dissected retinas immediately into 4% PFA and fix for 1 hour at room temperature.

  2. Manually aspirate PFA with a transfer pipette and wash retina with PBS + 0.1% Tween for 10 minutes on an orbital shaker at room temperature. Repeat this step 4 times.

    Manual aspiration is preferred to vacuum aspiration to prevent accidental aspiration of retina.

  3. Block retinas overnight at 4°C or for 1 hour at room temperature on an orbital shaker.

Day 2
  1. Move retinas to a 24-well plate and incubate in primary antibodies overnight at 4°C on an orbital shaker.

Day 3
  1. Move retinas back to the 12-well plate and wash with PBS + 0.1% Tween for 10 minutes at room temperature on an orbital shaker. Repeat four times.

  2. Move retinas back to 24-well plate and add secondary antibody in blocking solution for 1 hour at room temperature on an orbital shaker.

  3. Move retinas back to the 12-well plate and wash with PBS + 0.1% Tween for 10 minutes at room temperature on an orbital shaker. Repeat four times.

Mounting Retina onto Microscope Glass Slide

Day 3 continued
  1. Using a transfer pipette, place stained retina into 1X DPBS in a plastic weigh boat or similar sized vessel under a dissecting light microscope.

    Moving the retina with forceps can create tears in the tissue. Instead of using forceps, cut the tip of a transfer pipette at an angle such that the opening is larger than the retina. Move the retina with suction, as suctioning the retina with a transfer pipette should not damage the tissue.

  2. Cut retina into four leaflets using cuts at 90°. (Figure 13)

    Open in a separate window

    Figure 13.

    Schematic diagram showing a retina cup being cut at 90 degrees into a flattened retina with four leaflets. Created with BioRender.com.

  3. Place retina onto a microscope glass slide using a transfer pipette.

  4. Wick away DPBS with a kimwipe and flatten the retina by maneuvering the leaflets with straight forceps.

  5. Place 1–2 drops of ProLong Gold on retina and cover with a coverslip. Seal coverslip with nail polish and allow it to cure at 4C overnight or until ready to image.

Image Acquisition

Acquire fluorescence images of stained retina as desired. Confocal images are necessary to investigate the superficial and deep capillary plexuses independently. For quantification purposes in FIJI, it is recommended to acquire images that encompass the entire retina.

Quantification of Leukocytes with FIJI

  1. Open .nd2 file in FIJI.

  2. Use horizontal scroll bar to scroll to the channel of interest in .nd2 file.

  3. Adjust the brightness/contrast settings until your cells of interest are clear. To do this, go to Image > Adjust > Brightness/Contrast > Auto. If the “auto” option does not work well, you can manually adjust the settings in the pop-up window.

    Do NOT hit apply. As long as you do not hit “Apply”, you are only changing the way the data looks and not the data itself.

  4. Next you will duplicate your image, as it is good practice to work on duplicates and not the original file. To do this, go to Image > Duplicate > Unclick “Duplicate hyperstack” and type in the channel # you want to duplicate (ie 1, 2, or 3). Duplicate your channel of interest two times. One duplicate will be your “original”, and the other will be for “thresholding.”

“Threshold” duplicate

  1. In your “threshold” duplicate, choose a threshold strategy for your image that highlights your cells of interest. To do this, go to Image > Adjust > Threshold. Make sure “dark background” is ticked and “B&W” is selected under the second drop-down menu. In the first drop-down menu, scroll through the different threshold options until you get one that automatically highlights your cells of interest. Click “Apply” and close the window.

    It is ok if debris in the retina is also highlighted as we will remove debris in the next step. It is most important to ensure that the thresholding option you choose highlights the leukocytes/cells of interest.

  2. Next we will segment out debris. Go to Analyze > Analyze Particles > 300-infinity. Make sure “add manager” is ticked in the ROI pop-up window.

    The goal of this step is to segment out areas of your image you do not want FIJI to register as cells. You can change the 300 to any particle size. This segmentation tells FIJI that you want to highlight anything greater than 300 um2 (or the size you choose).

“Original” duplicate

  1. Now we will overlay the debris selections from step 6 over your “original” duplicate. Go to your “original” duplicate, click “show all” in the ROI manager until you see your debris selection on your original image. Click “More” in the ROI manager > Fill.

    This will “fill” the debris of your retina with a color and remove those data so that FIJI will not register it when you count cells later. Select the fill color in the color selector in the FIJI toolbar. You can choose whichever color you wish. In the ROI manager, More > Fill to fill in the color you chose. The resulting image is the image you want to analyze.

  2. Next you will measure the total area of the debris selections, as you will need to subtract this area from your selection of the whole retina later to calculate a “total retina area” to count cells in. In your ROI manager, there is a list of selections that correspond to the segmented debris. Select all points in the ROI manager, then Analyze > Measure in the menu at the top of your screen. The output is the area (um2) of the debris. Write this number down.

    You can save selections in the ROI manager by clicking More > Save.

    To ensure that “area” is the output that is measured, go to Analyze > Set measurements and make sure “area” is selected.

  3. Next, we will measure the area of retina to be analyzed. This will require you to calculate the area of the entire retina (including the debris). Go to your “original” duplicate that now has the debris filled out, select the “polygon” selection tool in the FIJI toolbar, and manually outline the entire retina. By hand drawing, you can get a count of “cells per area” and compare this in a standardized way. Once you have made your selection, go to your ROI manager and click “Add” to add your selection to the manager. In the manager, click on the selection you just added, and Analyze > Measure to calculate the area of your selection in um2. Note that this is not the final area. To find the total area of retina to count cells in, subtract “debris area” from the area you just measured. Write this number down.

    After making your selection, make sure you do not click anywhere else in the image because it will deselect your selection. If this happens, go to Edit > Selection > Restore Selection. Note that this will only restore your most recent selection.

    To save your selection, go to Analyze > Tools > ROI manager > More > Save

    To open or load your selection, go to Analyze > Tools > ROI manager > More > Open

  4. Next find and calculate the number of leukocytes in the retina. To do this, you must tell FIJI what you consider to be a leukocyte. While making sure the retina area you selected is still highlighted, zoom in to your tissue and click the “hand/scrolling tool” button in the FIJI toolbar to move to an area of the retina with leukocytes. Go to Process > Find maxima in the menu at the top of the screen. The number of maxima is your leukocyte count.

    Make sure “preview point selection” is ticked. The bigger the prominence, the fewer points you will have. Make sure you zoom into the tissue far enough to see differences in points selected based on how you change your prominence (ie when you increase or decrease prominence). Your tissue area selected may deselect during this process, so make sure you have saved your selection area per step 9 so you can reload it.

  5. Finally, quantify the number of leukocytes per retina by dividing your maxima calculated in step 10 by the final retina area calculated in step 9. This will give you # leukocytes/um2 retina.

Commentary

Background information:

This protocol is for visualizing extravasation of leukocytes in the retina and could be useful for testing anti-inflammatory agents in the eye. Inflammation may play a role in the pathogenesis of retinal diseases such as diabetic retinopathy and uveitis. The ability to visualize the course of inflammation (induction, extravasation, and resolution) can be helpful in studying disease pathology.

Critical Parameters:

The mouse eye has a diameter of only 3 mm and the retina is particularly delicate. Therefore, special attention should be paid to the intravitreal injection, as well as the retinal dissection and mounting steps. For the intravitreal injection, the experimenter should be careful to inject the inflammatory stimulus into the vitreous and not the lens. One way to check for successful injection is to practice injections using Evans blue dye and using a slit-lamp to visualize the retina after injection. If the retina is visible, the user likely injected the stimulus correctly; if the retina is opacified or blocked by blue dye, the user injected the dye into the lens. The dissection and mounting processes are also sensitive to user manipulation. For both, the experimenter needs to be careful not to tear the retina. Specific troubleshooting recommendations are outlined below.

Troubleshooting:

Understanding Results:

After following the steps of this procedure and acquiring fluorescent images of wholemount retina, the experimenter should be able to visualize leukocytes within the vasculature at earlier time points post-CCL2 injection (i.e., 8 hours) and leukocyte extravasation into the retinal tissue at later time points (i.e., 48 hours), as demonstrated in Figure 14. Using FIJI, the experimenter can quantify the number of leukocytes that have extravasated per mm2 area of retina for a standardized value.

Open in a separate window

Figure 14.

Inflammation in mouse retina with and without leukocyte extravasation. (A) 8 hours post intravitreal injection of CCL2 at 20x, all leukocytes remain within the vasculature (B) 48 hours post injection of CCL2 at 20x, leukocytes have extravasated out of the vasculature and into the retinal tissue. Depicted are Ccr2RFP leukocytes (red), Cx3cr1GFP microglia (green), and retinal vasculature (white). Scale bars are 75 μm.

Time Considerations:

There are several steps in the protocol that require technical expertise, and the timing for these steps will vary widely depending on the experience of the experimenter. For an experienced surgeon, approximately 5 minutes is needed per eye for injection of inflammatory stimulus, 10 minutes per eye for retinal dissection, and 5–10 minutes per eye for mounting. Time from intravitreal injection to sacrifice of the mouse will depend on what the experimenter is studying. Sacrifice 24 hours post CCL2 injection is appropriate if looking for both neutrophil and monocyte extravasation. A minimum of two days is required for immunofluorescence staining of wholemount retina.

In summary, it will take approximately five days from the first step of the protocol (anesthetizing mice for injection of inflammatory stimulus) to the last step of acquiring fluorescent images of stained retinas.

REAGENTS AND SOLUTIONS BY PROTOCOL:

Ketamine/Xylazine Anesthetic

Ketamine hydrochloride (Covetrus, NDC# 11695-0703-1) (Stock 100mg/ml), Final dosage - 100mg/kg of body weight (bwt) (2mg per 20g bwt)

Xylazine (Akorn Inc., NDC# 59399-110-20) (Stock 20mg/ml), Final dosage - 2mg/kg of bwt (0.04mg per 20g bwt)

2.5 ml of 10X PBS

17 mL of sterile water

Quick dosage guideline - 100ul for a 20g mouse. If the mouse has not entered the surgical plan of anesthesia by 10 min, administer an additional 25–50 ul.

Store at room temperature until drug expiration date

Avertin Anesthetic

2,2,2-Tribromoethanol, 99%

2-Methyl-2-butanol, 98%

1x PBS (without calcium or magnesium)

50ml syringe

0.45um syringe filter

  1. Dissolve 2.5g of 2,2,2-Tribromoethanol in 5ml of 2-Methyl-2-butanol by heating to 40°C while stirring on a stir plate.

  2. Add sterile PBS to a final solution volume of 200ml.

  3. Using a 50ml syringe and a 0.45μm filter, filter the Avertin into 50ml aliquots.

  4. Keep the aliquots at 4C protected from light for up to two weeks. Make new Avertin every two weeks or for every experiment.

Basic Protocol 1:

Bovine serum albumin (BSA) solution

1.25 g BSA

50 mL 1X DPBS

Mix and filter through a 0.2 micron filter.

Composition: 2.5% BSA (w/v)

Store up to 6 months at 4°C

Carrier mixture

200 μL olive oil

800 μL acetone

Always make fresh

Croton oil mixture

7.5 μL croton oil

492.5 μL carrier mixture

Shake the bottle of croton oil well before adding to carrier mixture.

Composition: 1.5% croton oil (v/v)

Always make fresh

Fixing solution

4g paraformaldehyde

90mL double-distilled water

6 drops 1N sodium hydroxide

10mL 10X Dulbecco’s phosphate-buffered saline (DPBS)

Stir paraformaldehyde and sodium hydroxide in double-distilled water over a hotplate.

Once the paraformaldehyde is dissolved, let cool to a temperature that allows safe handling, and add the 10X DPBS.

Maintain on ice until use.

Composition: 4% paraformaldehyde (w/v)

Store up to 1 month at −20°C.

Permeabilization buffer

200 mL normal goat serum (Jackson, cat. no. 005-000-121)

12 mL Triton X-100

3.8 mL BSA solution

Composition: 5% normal goat serum, 0.3% Triton X-100

Always make fresh

Basic Protocol 2:

Booster Dose Ketamine/Xylazine Initial Anesthesia co*cktail

(containing 25 mg/ml ketamine and 1.25 mg/ml xylazine)

2.5 ml Ketamine (Stock 100mg/ml), Final concentration - 25mg/ml (2mg per dose)

1.25 ml Xylazine (Stock 20mg/ml), Final dosage - concentration – 1.25 mg/ml

1 ml of 10X PBS

5.25 mL of sterile water

Supplemental dose guideline – 25 ul delivered intramuscular.

Store at room temperature until drug expiration date

Perfusion Buffer (pH 7.4, 37°C)

1 L sterile deionized H2O (LPS free)

1 packet of Tyrode’s salts

1 g Sodium Bicarbonate

Store at 4°C for up to 5 days

Measure the pH of the solution when it is 37°C. pH can change with temperature. pH should be checked and readjusted before each experiment.

Inflammatory stimulus

5ug of recombinant mouse IL-1β

Basic Protocol 5:

4% Paraformaldehyde Solution (pH 7–7.5)

For 100 mL of solution:

Heat 90 mL of ddH20 to 55–60C on a heater

Add 4g PFA powder with stirring (use magnetic stir bar)

Add 1–3 drops of NaOH, solution should clear

Add 10 mL of 10X DPBS without calcium & magnesium

Double check pH 7–7.5

All reagents should be added slowly in a fume hood

Blocking Solution

For 50 mL of solution:

150 μl Triton X-100 (Sigma Aldrich; Lot 53H0613)

25 μl Tween 20 (Sigma Aldrich; Lot # SLCC8017)

1.5 mL normal goat* serum (Jackson, Cat # 005-000-121)

Bring volume to 50 mL with HBSS (Corning #21-021-CV)

*Which serum you use depends on the species your secondary antibodies are raised in. Example: use normal goat serum if you are using goat secondary antibodies, normal donkey serum if using donkey secondary antibodies

Washing Solution (1X PBS + 0.1% Tween 20)

For 500 mL of washing solution:

Add 500 uL Tween 20* into 500 mL 1X DPBS

As Tween 20 is viscous and difficult to pipette, you can cut the tip of the pipette off on a slant to increase the size of the tip opening.

Table 5.

Troubleshooting Guide for Leukocyte Extravasation Analysis in Retina

ProblemPossible CauseSolution
Oversaturated points and nonspecific binding in fluorescence channel for leukocytesDebris in retinal dissection (choroid tissue, vitreous)Clean retina with straight forceps as much as possible prior to mounting; however, need to balance removing debris and not creating tears in retina tissue
Low fluorescence signalOverfixation of retinal tissueFix tissue for a shorter duration
Tears and holes in retinal tissuePuncturing the retina with forceps during dissection and/or mounting stepsPractice handling the retina more gently; have more retinas than needed for an experiment in case one retina becomes unusable
No inflammatory cells post 24 hours of intravitreal injection of CCL2Injected inflammatory stimulus into the lens of the eye instead of into the vitreous, or injection was not deep enough and inflammatory stimulus leaked out of the initial incisionPractice injections with Evans blue dye. Use a slit-lamp post dye injection to see if the retina is visible. If clearly visible, injection was done correctly; if retina is not visible, dye was injected into the lens. Ensure injection needle is 1–2 mm into the initial incision.

Open in a separate window

ACKNOWLEDGEMENTS:

Financial support – This work was supported by the National Institutes of Health through grant R35 HL155652 to WAM.

Footnotes

CONFLICT OF INTEREST STATEMENT:

VF: none; MH: none, VH: none, EA: none, JAL: none, DS: none, WAM: none

DATA AVAILABILITY STATEMENT:

The data, tools, and material (or their source) that support the protocol are available from the corresponding author upon reasonable request.

LITERATURE CITED:

  • Rutledge NS, Ogungbe FT, Watson RL, Sullivan DP, & Muller WA (2022). Human CD99L2 Regulates a Unique Step in Leukocyte Transmigration. Journal of Immunology (Baltimore, Md.: 1950), 209(5), 1001–1012. 10.4049/jimmunol.2101091 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  • Wu J, Cai Y, Wu X, Ying Y, Tai Y, & He M (2021). Transcardiac Perfusion of the Mouse for Brain Tissue Dissection and Fixation. Bio-Protocol, 11(5), e3988. 10.21769/BioProtoc.3988 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Methods for Imaging Inflammation and Transendothelial Migration in vivo and ex vivo (2024)

References

Top Articles
Latest Posts
Article information

Author: Mrs. Angelic Larkin

Last Updated:

Views: 6140

Rating: 4.7 / 5 (47 voted)

Reviews: 94% of readers found this page helpful

Author information

Name: Mrs. Angelic Larkin

Birthday: 1992-06-28

Address: Apt. 413 8275 Mueller Overpass, South Magnolia, IA 99527-6023

Phone: +6824704719725

Job: District Real-Estate Facilitator

Hobby: Letterboxing, Vacation, Poi, Homebrewing, Mountain biking, Slacklining, Cabaret

Introduction: My name is Mrs. Angelic Larkin, I am a cute, charming, funny, determined, inexpensive, joyous, cheerful person who loves writing and wants to share my knowledge and understanding with you.